• Media type: E-Article
  • Title: The Challenge of Treatment in Potential Celiac Disease
  • Contributor: Trovato, Chiara Maria; Montuori, Monica; Valitutti, Francesco; Leter, Beatrice; Cucchiara, Salvatore; Oliva, Salvatore
  • imprint: Hindawi Limited, 2019
  • Published in: Gastroenterology Research and Practice
  • Language: English
  • DOI: 10.1155/2019/8974751
  • ISSN: 1687-6121; 1687-630X
  • Origination:
  • Footnote:
  • Description: <jats:p>Potential celiac disease (PCD) is defined by the presence of positive serum antibodies, HLA-DQ2/DQ8 haplotypes, and a normal small intestinal mucosa (Marsh grade 0-1). This condition occurs in one-fifth of celiac disease (CD) patients and usually represents a clinical challenge. We reviewed genetic, histologic, and clinical features of this specific condition by performing a systematic search on MEDLINE, Embase, and Scholar database. Accordingly, we identified different genetic features in patients with PCD compared to the classical forms. Frequently, signs of inflammation (deposits of immunoglobulin A (IgA) and/or increased number of intraepithelial lymphocytes) can be clearly identify in the mucosa of PCD patients after an accurate histological assessment. Finally, the main challenge is represented by the treatment: the gluten-free diet should be considered only in the presence of gluten-dependent symptoms in both children and adults.<jats:italic>What is known</jats:italic>: (i) potential celiac disease (PCD) occurs in one-fifth of all celiac diseases (CD), and (ii) despite the absence of classical lesions, clear signs of inflammation are often detectable.<jats:italic>What is new</jats:italic>: (i) patients with PCD show different genetic features, and (ii) the presence of gluten-dependent symptoms is the main determinant to initiate the gluten-free diet, after a complete diagnostic work-up.</jats:p>
  • Access State: Open Access